Forbes March 27, 2025
Arthur L. Kellermann

Americans pay more for prescription drugs than citizens in any other country — so much more that the U.S. accounts for half of world sales revenue from pharmaceuticals, but only consumes 13% of the total volume of prescription drugs. Compared to other wealthy nations in the Organization for Economic Co-operation and Development, the U.S. accounts for 60% of pharmaceutical revenues but only 24% of volume, according to a recent issue brief from the U.S. Department of Health and Human Services. If Dr. Marty Makary, the newly confirmed commissioner of the U.S. Food and Drug Administration, wants to change this lopsided deal, the fight over weight loss drugs is a good place to start.

Why Are Brand-Name Drug Prices In The...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Faster Cancer Drug Approvals Tied to Clinical Benefits
Health policy roundup: Senate confirms NIH director, FDA commissioner
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years
Makary confirmed by Senate as FDA commissioner
Marty Makary and Jay Bhattacharya confirmed by Senate as FDA commissioner and NIH director

Share This Article